Showing results (61-70 of 91) with videos related to

Sort By:
Pageof 10
Journal of X-Ray Science and Technology|January 24, 2022
Automatic vs manual coronary CT angiography reconstruction for whole-heart coverage CT scanner: a comparison study in general patient populationCheng Yan, Jing Liu, Xue Yang, et al.
Annals of Hepatology|December 11, 2024
Assessing liver fibrosis in chronic liver disease: Comparison of diffusion-weighted MR elastography and two-dimensional shear-wave elastography using histopathologic assessment as the reference standardLi Yang, Guofeng Zhou, Liheng Liu, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|December 6, 2019
Endovascular management of transplant renal artery stenosis: A single-center retrospective studyYanqiao Ren, Fu Xiong, Xuefeng Kan, et al.
Heliyon|February 20, 2024
Radiation Dose and Image quality of coronary CT angiography performed with whole-heart coverage CT scanner with 0.25s rotation time in patients with irregular heart rhythmCheng Yan, Jing Liu, Ji Min, et al.
Future Oncology (London, England)|June 1, 2018
Lactic dehydrogenase to albumin ratio in prediction of unresectable pancreatic cancer with intervention chemotherapyShanshan Gao, Mengfei Wu, Yi Chen, et al.
Anti-Cancer Drugs|January 25, 2020
Platelet-to-lymphocyte ratio predicts therapy outcomes of transarterial chemoembolization plus apatinib in the treatment of advanced hepatocellular carcinomaLei Chen, Zunqian Ke, Fu Xiong, et al.
Oncotargets and Therapy|March 11, 2017
Combination of preoperative CEA and CA19-9 improves prediction outcomes in patients with resectable pancreatic adenocarcinoma: results from a large follow-up cohortGuofeng Zhou, Xiaoyu Liu, Xiaoyi Wang, et al.
Frontiers in Immunology|February 13, 2024
The impact of pulmonary artery to ascending aorta diameter ratio progression on the prognosis of NSCLC patients treated with immune checkpoint inhibitorsBingxin Gong, Yi Li, Yusheng Guo, et al.
BMC Cancer|April 26, 2024
Non-small cell lung cancer and immune checkpoint inhibitor therapy: does non-alcoholic fatty liver disease have an effect?Yi Li, Bingxin Gong, Yusheng Guo, et al.
Frontiers in Oncology|August 1, 2020
Transarterial Chemoembolization Combined With Apatinib for Advanced Hepatocellular Carcinoma: A Propensity Score Matching AnalysisXuefeng Kan, Bin Liang, Guofeng Zhou, et al.
Pageof 10